Clinical Researchers have released some good news about a possible treatment for coronavirus on Wednesday.
The US Food and Drug Administration has not yet approved any drugs for the treatment of the coronavirus. But it plans to announce an emergency-use authorization for remdesivir, according to The New York Times.
Data from the trial on more than 1,000 severely ill patients in 75 hospitals around the world show that patients put on the drug recovered 31% faster than similar patients who were given a placebo drug instead. Remdesivir cut recovery time from a median of 15 days to 11 days.
Scientists also suggested the drug could have an effect on survival. In the group on the drug, 8% died, compared with 11% among those given a placebo.
Remdesivir, made by the US company Gilead, is not a cure for Covid-19 and these results must be confirmed by more data, but experts think it could potentially help those who are acutely ill, probably in combination with other drugs that are yet to be shown to work. Multiple trials are taking place in hospitals around the world.